Skip to main content
OpenTrials
Completed

NCT Number: NCT05449210

Urdu Version of Parkinson's Disease Questionnaire: Reliability and Validity Study

In the study , the researchers will investigate the reliability and validity of Urdu version Parkinson's Disease Questionnaire in Pakistani population having Parkinsonism

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Ripah International University

Faisalabad, Punjab Province, 3800, Pakistan

About this study

The study is aimed to translate and culturally adapt Parkinson's Disease Questionnaire-39 into Urdu language and to investigate validity and reliability of Parkinson's Disease Questionnaire-39 in Parkinson's diseased patient among Pakistani population.The study will be a cross sectional survey in which non-probability purposive sampling technique will be used to enroll the participants into the study as per criteria.

The results of the study will help to establish an understanding of validity and reliability of Urdu version of Parkinson's Disease Questionnaire-39 with quality of life of Parkinson's Disease patients in Pakistani population having Parkinson's Disease. Reliability of the scale will be checked through internal consistency and test-retest methods. Cronbach's alpha value will be used to analyze internal consistency and for analyzing test-retest reliability an intraclass correlation coefficient with 195 patients will be used

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Idiopathic Parkinson's Disease
  • Minimum age of 40 years
  • Minimum level of 5 years of education
  • A score equal to or greater than 23 on the Mini-Mental State Examination
  • Patient experiencing at least two of the three cardinal symptoms of idiopathic Pairkinson Disease (rigidity, resting tremor, and bradykinesia.)

Exclusion criteria

  • Patients with non-idiopathic Parkinsonian variants
  • Patients with a history of drug or alcohol abuse in the last two years
  • Patients with unstable medical problems that may place the patient at increased risk or may interfere with the assessment or treatment of Parkinson's
  • Neurological operation on the brain within one year prior to study entry

Treatment and study plan

Primary outcomes

  1. Parkinson's Disease Questionnaire

    Time frame: 12th Week

    The Parkinson's Disease Questionnaire checks the quality of life of patients suffering from Parkinson Disease

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Reliability and Validity of Urdu Version of Parkinson's Disease Questionnaire in Pakistani Parkinson's Population

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jul 8, 2022
Registry last updated
Jan 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.